These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9261263)

  • 1. Persistent thrombin generation during heparin therapy in patients with acute coronary syndromes.
    Merlini PA; Ardissino D; Bauer KA; Oltrona L; Pezzano A; Bottasso B; Rosenberg RD; Mannucci PM
    Arterioscler Thromb Vasc Biol; 1997 Jul; 17(7):1325-30. PubMed ID: 9261263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rebound increase in thrombin generation and activity after cessation of intravenous heparin in patients with acute coronary syndromes.
    Granger CB; Miller JM; Bovill EG; Gruber A; Tracy RP; Krucoff MW; Green C; Berrios E; Harrington RA; Ohman EM
    Circulation; 1995 Apr; 91(7):1929-35. PubMed ID: 7895349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombin generation and activity during thrombolysis and concomitant heparin therapy in patients with acute myocardial infarction.
    Merlini PA; Bauer KA; Oltrona L; Ardissino D; Spinola A; Cattaneo M; Broccolino M; Mannucci PM; Rosenberg RD
    J Am Coll Cardiol; 1995 Jan; 25(1):203-9. PubMed ID: 7798503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant hirudin as a periprocedural antithrombotic in coronary angioplasty for unstable angina pectoris.
    Hafner G; Rupprecht HJ; Luz M; Terres W; Schindel F; Friesen HJ; Heinrichs H; Jessel A; Meyer J; Prellwitz W
    Eur Heart J; 1996 Aug; 17(8):1207-15. PubMed ID: 8869862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Failure of fixed dose intravenous heparin to suppress increases in thrombin activity after coronary thrombolysis with streptokinase.
    Galvani M; Abendschein DR; Ferrini D; Ottani F; Rusticali F; Eisenberg PR
    J Am Coll Cardiol; 1994 Nov; 24(6):1445-52. PubMed ID: 7930274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of enoxaparin and unfractionated heparin on thrombin generation in acute coronary syndromes without ST-segment elevation.
    Salvioni A; Casilli F; Assanelli E; Grazi M; Marenzi G; Guazzi MD
    Thromb Haemost; 2001 Oct; 86(4):991-4. PubMed ID: 11686357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reactivation of coagulation after stopping infusions of recombinant hirudin and unfractionated heparin in unstable angina and myocardial infarction without ST elevation: results of a randomized trial. OASIS Pilot Study Investigators. Organization to Assess Strategies for Ischemic++ Syndromes.
    Flather MD; Weitz JI; Yusuf S; Pogue J; Sussex B; Campeau J; Gill J; Schuld R; Joyner CD; Morris AL; Lai C; Théroux P; Marquis JF; Chan YK; Venkatesh G; Jessel A
    Eur Heart J; 2000 Sep; 21(17):1473-81. PubMed ID: 10952840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombin generation, inhibition and clinical outcomes in patients with acute myocardial infarction treated with thrombolytic therapy and heparin: results from the GUSTO-I Trial. GUSTO-I Hemostasis Substudy Group. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries.
    Granger CB; Becker R; Tracy RP; Califf RM; Topol EJ; Pieper KS; Ross AM; Roth S; Lambrew C; Bovill EG
    J Am Coll Cardiol; 1998 Mar; 31(3):497-505. PubMed ID: 9502626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for a rebound coagulation phenomenon after cessation of a 4-hour infusion of a specific thrombin inhibitor in patients with unstable angina pectoris.
    Gold HK; Torres FW; Garabedian HD; Werner W; Jang IK; Khan A; Hagstrom JN; Yasuda T; Leinbach RC; Newell JB
    J Am Coll Cardiol; 1993 Apr; 21(5):1039-47. PubMed ID: 8459055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of intravenous heparin infusion on thrombin-antithrombin complex and fibrinopeptide A in unstable angina.
    Mombelli G; Marchetti O; Haeberli A; Straub PW
    Am Heart J; 1998 Dec; 136(6):1106-13. PubMed ID: 9842027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct effects of recombinant desulfatohirudin (Revasc) and heparin on plasma levels of fibrinopeptide A and prothrombin fragment F1.2 in unstable angina. A multicenter trial.
    Rao AK; Sun L; Chesebro JH; Fuster V; Harrington RA; Schwartz D; Gallo P; Matos D; Topol EJ
    Circulation; 1996 Nov; 94(10):2389-95. PubMed ID: 8921778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistent activation of coagulation mechanism in unstable angina and myocardial infarction.
    Merlini PA; Bauer KA; Oltrona L; Ardissino D; Cattaneo M; Belli C; Mannucci PM; Rosenberg RD
    Circulation; 1994 Jul; 90(1):61-8. PubMed ID: 8026047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo thrombin generation and activity during and after intravenous infusion of heparin or recombinant hirudin in patients with unstable angina pectoris.
    Merlini PA; Ardissino D; Rosenberg RD; Colombi E; Agricola P; Oltrona L; Ottani F; Galvani M; Bauer KA; Bottasso B; Bertocchi F; Mannucci PM
    Arterioscler Thromb Vasc Biol; 2000 Sep; 20(9):2162-6. PubMed ID: 10978264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombin generation after the abrupt cessation of intravenous unfractionated heparin among patients with acute coronary syndromes: potential mechanisms for heightened prothrombotic potential.
    Becker RC; Spencer FA; Li Y; Ball SP; Ma Y; Hurley T; Hebert J
    J Am Coll Cardiol; 1999 Oct; 34(4):1020-7. PubMed ID: 10520784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Abciximab on prothrombin activation and thrombin generation in acute coronary syndromes without ST-segment elevation: Global Utilization of Strategies to Open Occluded Coronary Arteries Trial IV in Acute Coronary Syndromes (GUSTO IV ACS) Italian Hematologic Substudy.
    Merlini PA; Repetto A; Lombardi A; Vetrano A; Fetiveau R; Cavallini C; Sappè D; Salvioni A; Canziani R; Savonitto S; Mannucci PM; Ardissino D
    Circulation; 2002 Feb; 105(8):928-32. PubMed ID: 11864920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of markers of thrombin generation in patients with acute myocardial infarction complicated by ventricular fibrillation.
    Elmas E; Kaelsch T; Wolpert C; Sueselbeck T; Bertsch T; Dempfle CE; Borggrefe M
    Clin Cardiol; 2006 Apr; 29(4):165-9. PubMed ID: 16649726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antithrombin III supplementation for patients undergoing PTCA for unstable angina pectoris. A controlled randomized double-blind pilot study.
    Grip L; Blombäck M; Egberg N; Olsson A; Svane B; Velander M
    Eur Heart J; 1997 Mar; 18(3):443-9. PubMed ID: 9076381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of heparin-resistant thrombin activity with acute ischemic complications of coronary interventions.
    Oltrona L; Eisenberg PR; Lasala JM; Sewall DJ; Shelton ME; Winters KJ
    Circulation; 1996 Nov; 94(9):2064-71. PubMed ID: 8901652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of low-dose heparin on fibrinogen levels in patients with chronic ischemic heart disease.
    Prisco D; Paniccia R; Bandinelli B; Gori AM; Attanasio M; Giusti B; Comeglio M; Abbate R; Gensini GF; Serneri GG
    Int J Clin Lab Res; 1998; 28(3):170-3. PubMed ID: 9801927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of the hemostatic mechanism during thrombolysis in patients with unstable angina pectoris.
    Merlini PA; Ardissino D; Bauer KA; Oltrona L; Spinola A; Diotallevi P; Rosenberg RD; Mannucci PM
    Blood; 1995 Nov; 86(9):3327-32. PubMed ID: 7579435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.